Charles Morris

Technik-/Wissenschafts-/F&E-Leiter bei PRELUDE THERAPEUTICS INCORPORATED

61 Jahre

Health Technology

Consumer Services

Profil

Charles Q.
Morris is currently a Member at The Royal College of Physicians and Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon, Inc., Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016, Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012, Chief Medical Officer at Radius Health, Inc. from 2018 to 2020, Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP, Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018, and Chief Medical Officer at Celyad Oncology SA from 2021 to 2023.
Education includes undergraduate studies at the University of Sheffield Medical School.

Aktive Positionen von Charles Morris

Unternehmen	Position	Beginn
PRELUDE THERAPEUTICS INCORPORATED	Technik-/Wissenschafts-/F&E-Leiter	20.04.2026
The Royal College of Physicians The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	09.07.2010

Alle aktiven Positionen von Charles Morris

Ehemalige bekannte Positionen von Charles Morris

Unternehmen	Position	Ende
LAVA THERAPEUTICS N.V.	Technik-/Wissenschafts-/F&E-Leiter	01.10.2025
CELYAD ONCOLOGY SA	Technik-/Wissenschafts-/F&E-Leiter	01.01.2023
RADIUS HEALTH, INC.	Technik-/Wissenschafts-/F&E-Leiter	15.12.2020
Akamis Bio Ltd. Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies	Corporate Officer/Principal	01.09.2018
IMMUNOGEN, INC.	Corporate Officer/Principal	02.09.2016

Sehen Sie sich die Erfahrung von Charles Morris im Detail an

Ausbildung von Charles Morris

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Charles Morris im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	11
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics	Health Technology
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Health Technology
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics	Health Technology
AstraZeneca Pharmaceuticals LP AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals	Health Technology
The Royal College of Physicians The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Celyad Oncology SA Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products	Health Technology
Akamis Bio Ltd. Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies	Health Technology
Prelude Therapeutics, Inc. Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases	Health Technology
LAVA Therapeutics NV LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer	Health Technology
University of Sheffield Medical School University of Sheffield Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services